Skip to main content Skip to main navigation menu Skip to site footer
Articles
Published: 2021-11-23

Evaluation of chest computed tomography features in COVID-19: a single-center retrospective study

Shukla Diagnostic Center, Balaghat, Madhya Pradesh – 480001, India
Shukla Diagnostic Center, Balaghat, Madhya Pradesh – 480001, India
Shukla Diagnostic Center, Balaghat, Madhya Pradesh – 480001, India
COVID-19, Computed Tomography, Lung Disease, Reverse Transcriptase Polymerase Chain Reaction, SARS-Cov-2, India

Abstract

Background: Even though Real-Time Polymerase Chain Reaction (RT-PCR) is a gold standard for confirming COVID-19, it continues to be plagued by a lack of RT-PCR kits and the potential of false-negative results. Hence, during the second wave of COVID-19 in India, Computed Tomography (CT) scan is an emerging diagnostic tool in evaluating the severity of illness in COVID-19 pneumonia. The present study endeavored to assess chest CT features of COVID-19 pneumonia in Indian population.

Methods: This was a single-center, retrospective, observational study conducted in 300 consecutive adults RT-PCR confirmed COVID-19 patients from 1, Jan 2021 to 31, March 2021 at a private radio diagnostic center.  Data regarding baseline demographics, clinical and laboratory characteristics, extent, pattern, and type of abnormal CT findings were noted.

Results: The study population (204 males and 108 females) had mean age of 43.18 ± 8.27 years.  Our study's most common clinical presentation was cough (48.1%) and fever (47.1%), respectively. Lung parenchymal abnormalities were found in 294 (94.2%) patients. Abnormal CT findings revealed the involvement of bilateral (45.6%) and multilobar (42.9%) with a predominant peripheral (92.3%) and posterior (80.8%) distribution. According to the type of opacity, Ground Glass Opacity (GGO) was the dominant abnormality found in 270 (91.8%) patients, in which pure GGO (36.7%), GGO with crazy paving pattern (39.8%), and GGO mixed with consolidation (52.0 %) were noted. Peri-lesional or intralesional segmental or subsegmental pulmonary vessel enlargement was found in 192 (65.3 %) patients.

Conclusion: During the second wave of COVID-19, a chest CT scan is a modality of choice in diagnosing COVID-19 pneumonia and related lung parenchymal changes.



Downloads

Download data is not yet available.


How to Cite

1.
Shukla AS, Shukla SR, Daruwala FR. Evaluation of chest computed tomography features in COVID-19: a single-center retrospective study. jidhealth [Internet]. 2021 Nov. 23 [cited 2024 Apr. 26];4(4):588-94. Available from: https://jidhealth.com/index.php/jidhealth/article/view/172